Hancom Lifecare Inc

Hancom Lifecare Inc has a strong liquidity position, with cash and equivalents amounting to KRW 10,510,215,160, which is significantly higher than its short-term liabilities. The company's liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The current ratio of 1.76 further supports this, showing that the company has 1.76 times more current assets than current liabilities.

Profitability metrics for Hancom Lifecare Inc are currently negative, with a return on equity (ROE) of -0.3% and a return on assets (ROA) of -0.19%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is negative at KRW -846,975,470, and the net income is also negative at KRW -384,350,620, reflecting ongoing operational challenges.

The company's revenue is primarily concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk associated with the company's revenue streams. The absence of detailed segment and geographic data limits the ability to assess the company's exposure to different markets and potential growth areas.

Looking ahead, Hancom Lifecare Inc is expected to face continued challenges in the current fiscal year, with no significant revenue growth projected. The company's operating cash flow is negative at KRW -7,229,821,080, which may impact its ability to fund operations and invest in growth initiatives. The free cash flow of KRW 467,599,010 is modest and may not be sufficient to support long-term strategic goals.

The risk assessment for Hancom Lifecare Inc indicates low liquidity and dilution risks, with no immediate filing-based flags detected. However, the company's negative net income and operating income suggest potential financial instability. The dilution potential is low, and there are no significant adjustments applied to the valuation metrics, indicating that the company's financial position is not currently under severe pressure.

Recent events and filings do not show any significant developments that would impact the company's financial position or strategic direction. The absence of recent major events or disclosures suggests a stable but stagnant business environment for Hancom Lifecare Inc.

Hancom Lifecare maintains a conservative debt-to-equity ratio of 0.03, significantly below the cohort median of 0.20.

The company exhibits best-in-class cash conversion at 18.81, vastly outperforming the cohort median of 0.84.

Low dilution and liquidity risks suggest stable capital structure and adequate market trading conditions for investors.

Gross profit remained substantial at 21.4 billion KRW in FY0, indicating underlying product margin resilience despite losses.

The company faces high credit risk, contrasting with its low dilution and liquidity risk profiles.